Company Analysis

Cuprina Holdings (Cayman) Limited (CUPR)

Nasdaq: CUPR · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Singapore, SG · filing with the SEC since 2023
Grade4.0
◀ Past 4.1● Present 3.0▶ Future 5.2
4 est.
The companyfiscal 2025, as filed
RevenueSGD 49,894+3.3%
Net incomen/a
Earnings per shareSGD -22.83-163.0%
Operating cash flow-SGD 9.1M-639.0%
CashSGD 3.1M+2576.8%
DebtSGD 164,929-24.7%
Shareholders’ equitySGD 5.1M+213.4%
Shares, diluted20.5M
Return on equityn/a
The recordfrom its filings
Filings in 202627
Newest filingNov 6 · SCHEDULE 13G/A
Annual reportApr 27, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer category<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
22232425
As filed, in SGD. Nothing here is a forecast.

News

Sep 16, 2026 · SEC EDGAR · Form 424B4
Offering prospectus
Open the filing on sec.gov
Sep 15, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
Jul 28, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton CUPR · research, not advice